Поиск | ValuTok

Vanshika Swami добавлена новая статья Другое
2026-03-13 05:43:58

Biologics and Biosimilars Market by 2031 – Segmentation Analysis, Trends, and Key Players
The biologics and biosimilars market is poised for significant growth over the next decade, driven by rising demand for advanced therapies to treat chronic, autoimmune, and life-threatening diseases. Biologics, complex medicines derived from living organisms, are increasingly preferred for their targeted therapeutic effects, while biosimilars offer highly similar alternatives at reduced costs,...

0 Комментарии 0 Поделились 449 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Naznin Shaikh добавлена новая статья Dance
2026-03-09 07:10:24

Biosimilars Market Opportunities for Pharma and Biotech Companies
The increasing role of biosimilars in hospital treatment protocols is another factor driving market growth. Hospitals are adopting biosimilars to manage healthcare budgets effectively. This shift is improving patient access to essential biologic therapies. The global Biosimilars Market is experiencing remarkable growth as healthcare systems increasingly adopt cost-effective alternatives...

0 Комментарии 0 Поделились 855 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rahul Rangwa добавлена новая статья Другое
2026-02-12 04:22:50

Europe Adalimumab Market Accelerates as Biosimilars Drive Competitive Expansion and Cost Efficiency
"Executive Summary Europe Adalimumab Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses that the market is growing with a CAGR of 16.2% in the forecast period of 2022 to 2029 and is expected to reach USD 10,337.79 million by 2029 from USD 3,485.94 million in 2021. Each of the topics covered in the Europe Adalimumab report is studied very...

0 Комментарии 0 Поделились 790 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Komal Galande добавлена новая статья Music
2026-02-12 06:02:28

Is the Global EPO Drugs Market Expanding With Rising Chronic Kidney Disease and Anemia Cases?
Executive Summary Erythropoietin (EPO) Drugs Market Size and Share Forecast The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period The Erythropoietin (EPO) Drugs report also makes available CAGR value fluctuation...

0 Комментарии 0 Поделились 996 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!